London Production of Be More Chill Reboots for a 10-Week Run Beginning June 30 | Playbill

London News London Production of Be More Chill Reboots for a 10-Week Run Beginning June 30 The musical, which opened in the U.K. in February 2020, returns with its full original London cast and creative team.
Matt Crockett

The London production of Be More Chill gets another life in the West End for a strictly limited 10-week run at the Shaftesbury Theatre beginning June 30 through September 5.

The musical opened in the U.K. in February 2020, just before the pandemic forced the closure of theatres. It will return with its full original London cast starring Scott Folan as Jeremy Heere, Blake Patrick Anderson as Michael Mell, Miracle Chance as Christine Canigula, and Stewart Clarke as The Squip, along with Eloise Davies, Christopher Fry, James Hameed, Gabriel Hinchliffe, Renée Lamb, Eve Norris, Millie O’Connell, and Miles Paloma.

Based on the novel by Ned Vizzini, Be More Chill tells the story of an unpopular teen who takes a supercomputer pill to become cool—only to discover that the A.I. inside wants to take over the world. The musical features a Tony-nominated score by Joe Iconis and a book by Joe Tracz.

The original Broadway creative team also returns to create the London production under the helm of director Stephen Brackett. Chase Brock choreographs, with set design by Beowulf Boritt, costume design by Bobby Frederick Tilley, lighting design by Tyler Micoleau, sound design by Ryan Rumery, and projection design by Alex Basco Koch. Musical supervision and orchestrations are by Charlie Rosen and music vocal arrangements by Emily Marshall. Gavin Mitford serves as associate director for the London production, with U.K. casting by Will Burton.

Following government guidance, seating will be socially-distanced for at least the first three weeks of production and reevaluated July 19.

Tickets are available here.

Production Photos: Be More Chill in London

Recommended Reading:

Blocking belongs
on the stage,
not on websites.

Our website is made possible by
displaying online advertisements to our visitors.

Please consider supporting us by
whitelisting with your ad blocker.
Thank you!